Suppr超能文献

帕金森病中多巴胺激动剂的使用与冲动控制障碍的关联

Association of dopamine agonist use with impulse control disorders in Parkinson disease.

作者信息

Weintraub Daniel, Siderowf Andrew D, Potenza Marc N, Goveas Joseph, Morales Knashawn H, Duda John E, Moberg Paul J, Stern Matthew B

机构信息

Department of Psychiatry, University of Pennsylvania, and Parkinson's Disease Research, Education, and Clinical Center, USA.

出版信息

Arch Neurol. 2006 Jul;63(7):969-73. doi: 10.1001/archneur.63.7.969.

Abstract

OBJECTIVE

To determine the frequency and correlates of impulse control disorders (ICDs) in Parkinson disease (PD).

DESIGN

An unstructured screening interview for ICDs (compulsive gambling, buying, and sexual behavior) followed by a telephone-administered structured interview for screen-positive patients.

SETTING

Two university-affiliated movement disorders centers.

PARTICIPANTS

A convenience sample of 272 patients with idiopathic PD who were screened for psychiatric complications.

MAIN OUTCOME MEASURES

Presence of compulsive gambling, buying, or sexual behavior as assessed by the Minnesota Impulsive Disorders Interview.

RESULTS

Eighteen patients (6.6%) with PD met criteria for an ICD at some point during the course of PD, including 11 (4.0%) with an active ICD. Compulsive gambling and compulsive sexual behavior were equally common. In a multivariate model, treatment with a dopamine agonist (P = .01) and a history of ICD symptoms prior to PD onset (P = .02) predicted current ICD. There were no differences between the dopamine agonists in their association with ICDs (P = .21), and daily doses of dopamine agonists were higher in patients with an ICD than in dopamine agonist-treated patients without an ICD (P < .001).

CONCLUSIONS

Patients with PD treated with a dopamine agonist should be made aware of the risk of developing an ICD and monitored clinically. Because dopamine agonists are increasingly being used for other indications, future research should assess the dopamine agonist-associated risk for ICDs in other populations.

摘要

目的

确定帕金森病(PD)中冲动控制障碍(ICD)的发生率及其相关因素。

设计

对ICD(强迫性赌博、购物和性行为)进行非结构化筛查访谈,随后对筛查呈阳性的患者进行电话结构化访谈。

地点

两个大学附属医院的运动障碍中心。

参与者

对272例特发性PD患者进行便利抽样,筛查其精神并发症。

主要观察指标

通过明尼苏达冲动障碍访谈评估强迫性赌博、购物或性行为的存在情况。

结果

18例(6.6%)PD患者在PD病程中的某个时间点符合ICD标准,其中11例(4.0%)患有活动性ICD。强迫性赌博和强迫性行为同样常见。在多变量模型中,多巴胺激动剂治疗(P = 0.01)和PD发病前有ICD症状史(P = 0.02)可预测当前的ICD。不同多巴胺激动剂与ICD的关联无差异(P = 0.21),且ICD患者的多巴胺激动剂每日剂量高于无ICD的多巴胺激动剂治疗患者(P < 0.001)。

结论

接受多巴胺激动剂治疗的PD患者应意识到发生ICD的风险,并进行临床监测。由于多巴胺激动剂越来越多地用于其他适应证,未来研究应评估其他人群中多巴胺激动剂与ICD相关的风险。

相似文献

1
Association of dopamine agonist use with impulse control disorders in Parkinson disease.
Arch Neurol. 2006 Jul;63(7):969-73. doi: 10.1001/archneur.63.7.969.
2
Compulsive behaviors in patients with Parkinson's disease.
Neurologist. 2010 May;16(3):192-5. doi: 10.1097/NRL.0b013e31819f952b.
5
The risky business of dopamine agonists in Parkinson disease and impulse control disorders.
Behav Neurosci. 2011 Aug;125(4):492-500. doi: 10.1037/a0023795.
6
Impulse Control and Related Disorders in Parkinson's Disease.
Int Rev Neurobiol. 2017;133:679-717. doi: 10.1016/bs.irn.2017.04.006. Epub 2017 Jun 1.
7
[Impulsive-compulsive syndrome in Parkinson's disease].
Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(7 Pt 2):32-8.
8
Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
J Neurol Neurosurg Psychiatry. 2014 Aug;85(8):840-4. doi: 10.1136/jnnp-2013-306787. Epub 2014 Jan 16.
9
Impulse control disorders in Parkinson's disease.
Curr Neurol Neurosci Rep. 2006 Jul;6(4):302-6. doi: 10.1007/s11910-006-0022-y.
10
Prospective cohort study of impulse control disorders in Parkinson's disease.
Mov Disord. 2013 Mar;28(3):327-33. doi: 10.1002/mds.25291. Epub 2013 Jan 2.

引用本文的文献

1
Noradrenergic therapies in neurodegenerative disease: from symptomatic to disease modifying therapy?
Brain Commun. 2025 Aug 25;7(5):fcaf310. doi: 10.1093/braincomms/fcaf310. eCollection 2025.
2
Bidirectional modulation of reward-guided decision making by dopamine.
Psychopharmacology (Berl). 2025 May 29. doi: 10.1007/s00213-025-06816-9.
4
EAAT2 Activation Regulates Glutamate Excitotoxicity and Reduces Impulsivity in a Rodent Model of Parkinson's Disease.
Mol Neurobiol. 2025 May;62(5):5787-5803. doi: 10.1007/s12035-024-04644-0. Epub 2024 Dec 4.
5
The dopamine hypothesis for ADHD: An evaluation of evidence accumulated from human studies and animal models.
Front Psychiatry. 2024 Nov 15;15:1492126. doi: 10.3389/fpsyt.2024.1492126. eCollection 2024.
6
Impulse control disorders and other non-motor symptoms in Sri Lankan patients with Parkinson's disease.
PLoS One. 2024 Oct 18;19(10):e0312342. doi: 10.1371/journal.pone.0312342. eCollection 2024.
8
Sex differences in risk-based decision-making and the modulation of risk preference by dopamine-2 like receptors in rats.
Neuropharmacology. 2024 May 1;248:109851. doi: 10.1016/j.neuropharm.2024.109851. Epub 2024 Feb 6.
9
Dopamine agonist serum concentrations and impulse control disorders in Parkinson's disease.
Eur J Neurol. 2024 Feb;31(2):e16144. doi: 10.1111/ene.16144. Epub 2023 Nov 13.
10
Time perception reflects individual differences in motor and non-motor symptoms of Parkinson's disease.
Parkinsonism Relat Disord. 2023 Sep;114:105800. doi: 10.1016/j.parkreldis.2023.105800. Epub 2023 Aug 7.

本文引用的文献

1
Impulse control disorders in adult psychiatric inpatients.
Am J Psychiatry. 2005 Nov;162(11):2184-8. doi: 10.1176/appi.ajp.162.11.2184.
3
Pathological gambling caused by drugs used to treat Parkinson disease.
Arch Neurol. 2005 Sep;62(9):1377-81. doi: 10.1001/archneur.62.9.noc50009. Epub 2005 Jul 11.
4
Two-year follow-up of subthalamic deep brain stimulation in Parkinson's disease.
Mov Disord. 2003 Nov;18(11):1332-7. doi: 10.1002/mds.10518.
5
Pathological gambling associated with dopamine agonist therapy in Parkinson's disease.
Neurology. 2003 Aug 12;61(3):422-3. doi: 10.1212/01.wnl.0000076478.45005.ec.
7
An algorithm (decision tree) for the management of Parkinson's disease (2001): treatment guidelines.
Neurology. 2001 Jun;56(11 Suppl 5):S1-S88. doi: 10.1212/wnl.56.suppl_5.s1.
8
Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment?
Mov Disord. 2000 Sep;15(5):869-72. doi: 10.1002/1531-8257(200009)15:5<869::aid-mds1016>3.0.co;2-i.
9
Hedonistic homeostatic dysregulation in patients with Parkinson's disease on dopamine replacement therapies.
J Neurol Neurosurg Psychiatry. 2000 Apr;68(4):423-8. doi: 10.1136/jnnp.68.4.423.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验